These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Early-onset generalized dystonia starting in the lower extremities in a patient with a novel ANO3 variant. Yoo D; Kim HJ; Lee JS; Lee S; Kim SY; Choi M; Chae JH; Jeon B Parkinsonism Relat Disord; 2018 May; 50():124-125. PubMed ID: 29449182 [No Abstract] [Full Text] [Related]
6. A novel ANO3 variant in two siblings with different phenotypes. Esposito M; Trinchillo A; Piceci-Sparascio F; D'Asdia MC; Consoli F; De Luca A Parkinsonism Relat Disord; 2023 Jun; 111():105413. PubMed ID: 37116293 [TBL] [Abstract][Full Text] [Related]
7. Novel heterozygous mutation in ANO3 responsible for craniocervical dystonia. Miltgen M; Blanchard A; Mathieu H; Kreisler A; Jean-Pierre-Desvignes ; Salgado D; Roubertie A; Barre L; Rai G; Blanck V; Frederic M; Douay X; Mazzolenni R; Charpentier P; Gonzalez V; Destée A; Béroud C; Collod-Béroud G Mov Disord; 2016 Aug; 31(8):1251-2. PubMed ID: 27392807 [No Abstract] [Full Text] [Related]
8. The Clinical Spectrum of ANO3-Report of a New Family and Literature Review. Percetti M; Zini M; Soliveri P; Cogiamanian F; Ferrara M; Orunesu E; Ranghetti A; Ferrarese C; Pezzoli G; Garavaglia B; Isaias IU; Sacilotto G Mov Disord Clin Pract; 2024 Mar; 11(3):289-297. PubMed ID: 38284143 [TBL] [Abstract][Full Text] [Related]
9. Combined occurrence of deleterious TOR1A and ANO3 variants in isolated generalized dystonia. Miocinovic S; Vengoechea J; LeDoux MS; Isbaine F; Jinnah HA Parkinsonism Relat Disord; 2020 Apr; 73():55-56. PubMed ID: 32248052 [No Abstract] [Full Text] [Related]
10. ANO3 as a Cause of Early-Onset Chorea Combined with Dystonia: Illustration of Phenotypic Evolution. Romito LM; Leta V; Garavaglia B; Panteghini C; Zorzi G; Elia AE; Colucci F; Carecchio M; Eleopra R Mov Disord; 2024 Jan; 39(1):220-221. PubMed ID: 38073131 [No Abstract] [Full Text] [Related]
11. The expanding clinical and genetic spectrum of ANO3 dystonia. Jiang LT; Li LX; Liu Y; Zhang XL; Pan YG; Wang L; Wan XH; Jin LJ Neurosci Lett; 2021 Feb; 746():135590. PubMed ID: 33388357 [TBL] [Abstract][Full Text] [Related]
12. Reply to: "Heterogeneous Phenotypic Evolution in ANO3-Related Dystonia Due to the Recurrent p.Glu510Lys Variant". Romito LM; Leta V; Garavaglia B; Panteghini C; Zorzi G; Elia AE; Colucci F; Carecchio M; Eleopra R Mov Disord; 2024 Mar; 39(3):632-633. PubMed ID: 38525607 [No Abstract] [Full Text] [Related]
13. Heterogeneous Phenotypic Evolution in ANO3-Related Dystonia Due to the Recurrent p.Glu510Lys Variant. Indelicato E; Boesch S; Zech M Mov Disord; 2024 Mar; 39(3):631-632. PubMed ID: 38525591 [No Abstract] [Full Text] [Related]
14. Broadening the clinical spectrum: molecular mechanisms and new phenotypes of ANO3-dystonia. Ousingsawat J; Talbi K; Gómez-Martín H; Koy A; Fernández-Jaén A; Tekgül H; Serdaroğlu E; Schreiber R; Ortigoza-Escobar JD; Kunzelmann K Brain; 2024 Jun; 147(6):1982-1995. PubMed ID: 38079528 [TBL] [Abstract][Full Text] [Related]
15. Role of ANO3 mutations in dystonia: A large-scale mutational screening study. Olschewski L; Jesús S; Kim HJ; Tunc S; Löns S; Junker J; Zeuner KE; Kühn AA; Kuhlenbäumer G; Schäffer E; Berg D; Kasten M; Ferbert A; Altenmüller E; Brüggemann N; Bauer P; Rolfs A; Jeon B; Bäumer T; Mir P; Klein C; Lohmann K Parkinsonism Relat Disord; 2019 May; 62():196-200. PubMed ID: 30712998 [TBL] [Abstract][Full Text] [Related]
16. Craniocervical dystonia with levodopa-responsive parkinsonism co-segregating with a pathogenic ANO3 mutation in a Taiwanese family. Kuo MC; Lin HI; Lin CH Parkinsonism Relat Disord; 2019 May; 62():236-238. PubMed ID: 30692049 [No Abstract] [Full Text] [Related]
18. Genetic spectrum and clinical features in a cohort of Chinese patients with isolated dystonia. Li LX; Liu Y; Huang JH; Yang Y; Pan YG; Zhang XL; Pan LZ; Jin LJ Clin Genet; 2023 Apr; 103(4):459-465. PubMed ID: 36648081 [TBL] [Abstract][Full Text] [Related]
19. A step toward essential tremor gene discovery: identification of extreme phenotype and screening of HTRA2 and ANO3. Renaud M; Marcel C; Rudolf G; Schaeffer M; Lagha-Boukbiza O; Chanson JB; Chelly J; Anheim M; Tranchant C BMC Neurol; 2016 Nov; 16(1):238. PubMed ID: 27881096 [TBL] [Abstract][Full Text] [Related]